GLP-1 Drugs: How They Reshape Spending Habits

New survey reveals GLP-1 drug users are slashing restaurant budgets. How do these meds reshape lifestyles? Click to uncover surprising...

04/05/2025

0 views

Roche’s $5.3B Obesity Drug Deal Unveiled

Roche’s $5.3B bet on Zealand’s petrelintide could redefine obesity treatment. Will it outshine giants like Novo Nordisk? Click to uncover...

02/05/2025

0 views

Struggling with weight loss? Telehealth now offers easy access to treatments like Wegovy, but how does it work and what’s...

29/04/2025

0 views

Telehealth stocks are at a crossroads post-GLP-1 shortage. What’s driving the shift, and where’s the market headed? Dive into the...

29/04/2025

0 views

Telehealth weight loss drugs promise quick results, but are they safe? Uncover the risks and legal battles shaking up the...

23/04/2025

0 views

Roche's $50B U.S. bet creates thousands of jobs and new facilities. Will it shield pharma from tariffs? Click to uncover...

22/04/2025

0 views